Member Info for Timster

Still watching .......

Still nothing learned....

When's the big reveal??

Collaborations
The COVID-19 crisis has brought together the scientific community like never before. Our global team is helping to accelerate the work of researchers, developers, and manufacturers of diagnostics and vaccines, to bring access to much-needed solutions for COVID-19.

Genedrive: PCR assay to detect SARS-CoV-2
Sona Nanotech: rapid response lateral flow test
Avacta: Affimer-based point-of-care rapid screening test
University of Queensland: vaccine

its ****** because there are also lots of different time zones in the US

not obsessed, just trying to explain the trend. You can see for yourself the pattern pretty much everyday.

It is possible for there to be a 1pm RNS just because they never have doesn't mean they cant!

told you what it is, 1pm RNS speculators off somewhere else now

its the 1pm RNS speculators moving on

208 million shares in issue

2000000000/208000000 = £9.61

been posted earlier...

As many have said it reads very much as if the two test prototypes are ready and tested. RNS coming along soon perhaps

they do, it reads as if the Cytiva test is a done deal :)

its the psychology of passing the round numbers in SP :)

thanks Richob, he seems like a very useful man to have on board when this was posted in the last RNS:

Avacta has now demonstrated that several Affimer reagents also perform this blocking function and the Company is now seeking a partner that has the resources available to develop a neutralising Affimer therapy as quickly as possible.

Look at Paul Fry's CV:
Paul has also served as Director of Global Finance Operations at Vodafone plc and spent more than 25 years at GlaxoSmithKline (“GSK”), where he held a number of senior roles including Head of Global Finance Services and Chief Financial Officer for GSK's Italian pharmaceutical business.

This may well be Avacta!

https://twitter.com/Stockonomist/status/1262272507190575104

at least he's not posting the price every 2 mins.

Great summary, I'll check back at 7am for the £100 a share RNS!!!!

Probably been posted

https://www.news-medical.net/amp/news/20200515/Developing-a-COVID-19-Antigen-Test.aspx?__twitter_impression=true

Great posts!!!

Just a very small example of where our test can be used. I play league squash in Wales and we've just been notified that it's likely that any matches will not be played until at least September!! Now if we had a 10 min test then we could continue!!
Scale that up across the world for every sport at every level, live entertainment, airports, ferries, workplaces, etc etc

could well be MASSIVE

new partners, two tests prototypes!

not only tests but treatment options now!!! the market potential is Mental!

onwards and upwards!!

the board bickering is amusing but the quality posts are much more interesting for those interested in the company as a whole. its not just about COVID (but its obviously helping)

probably been said many times but you definitely wouldn't want to be out of this over the weekend.

these fellas working 7 days a week development wont stop for 2 days....

fully funded till 2022!
today's RNS is about attracting big money partners I believe so no need for raise

Great RNS!! bit odd though its almost like they are saying to AstraZeneca and GSK that they are waiting their time and should come to Avacta. Perhaps they had already spoken and weren't interested? they should be now though!!!

soon though we could have a test and a treatment, doubly mind blowing !!!:

I look forward to updating the market further on this and on the development of a COVID-19 antigen rapid saliva test with Cytiva which continues apace."